Sodium valproate -- induced skeletal myopathy.
Indian J Pediatr
;
2005 Mar; 72(3): 243-4
Artículo
en Inglés
| IMSEAR
| ID: sea-83151
ABSTRACT
The authors report a case of skeletal myopathy in a four-year-old boy on long-term sodium valproate therapy for secondary epilepsy due to neurocysticercosis. He presented with clinical features of limb girdle weakness. EMG revealed features of myopathy. Carnitine deficiency due to sodium valproate was suspected and plasma carnitine levels were found to be low. Sodium valproate was withdrawn. L-carnitine supplementation resulted in marked clinical recovery as well as rise in plasma carnitine levels.
Texto completo:
Disponible
Índice:
IMSEAR (Asia Sudoriental)
Asunto principal:
Deficiencia de Vitamina B
/
Humanos
/
Masculino
/
Carbamazepina
/
Carnitina
/
Preescolar
/
Ácido Valproico
/
Epilepsia
/
Enfermedades Musculares
/
Anticonvulsivantes
Idioma:
Inglés
Revista:
Indian J Pediatr
Año:
2005
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS